Market Place
Sourcing Support
WuXi AppTec`s Couvet Site Earns EcoVadis 2024 Silver Medal
14 Nov 2024 //
PR NEWSWIRE
Wuxi Apptec Named Global Crdmo Company Of The Year Again
29 Oct 2024 //
PR NEWSWIRE
WuXi AppTec Maintains AA MSCI ESG Rating For Fourth Consecutive Year
01 Sep 2024 //
PR NEWSWIRE
US clinical trials in China questioned by US lawmakers
21 Aug 2024 //
REUTERS
With BIOSECURE Act looming, WuXi AppTec shows declining revenue
31 Jul 2024 //
FIERCE PHARMA
Members of Congress buy & sell stocks that would gain from bill China biotech
20 May 2024 //
ENDPTS
BIO CEO defends the organization`s about-face on the Biosecure Act
09 May 2024 //
ENDPTS
WuXi wants to regain client confidence amid claims of IP transfer to Chinese
29 Apr 2024 //
ENDPTS
Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi
24 Apr 2024 //
ENDPTS
WuXi builds out lobbying bench amid legislative effort to blacklist company
03 Apr 2024 //
ENDPTS
Additional drugmakers flag risks working with WuXi amid heightened US scrutiny
02 Apr 2024 //
ENDPTS
Lead House sponsor of WuXi-linked bill to leave Congress early
22 Mar 2024 //
ENDPTS
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023
18 Mar 2024 //
PR NEWSWIRE
WuXi AppTec`s 2023 sales largely reliant on the US, report says
18 Mar 2024 //
ENDPTS
Biotech trade association to split with China`s WuXi AppTec
14 Mar 2024 //
REUTERS
WuXi became a critical partner to biopharma companies
13 Mar 2024 //
ENDPTS
U.S. Legislation Seeking Sanctions on BGI, WuXi Apptec Advances
08 Mar 2024 //
CONTRACT PHARMA
Senate committee advances bill targeting Chinese manufacturers
06 Mar 2024 //
ENDPTS
WuXi AppTec subsidiary to manufacture Iovance’s solid tumor TIL therapy in US
20 Feb 2024 //
ENDPTS
Lawmakers press for sanctions on WuXi AppTec, Biologics: Reuters
13 Feb 2024 //
FIERCE PHARMA
US lawmakers call for sanctions on China`s WuXi AppTec biotech firm
12 Feb 2024 //
REUTERS
WuXi AppTec plays defense against `unfounded` allegations
05 Feb 2024 //
FIERCE PHARMA
China`s WuXi AppTec rebuts US bill claims of government ties, shares volatile
04 Feb 2024 //
REUTERS
WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over biotech bill
02 Feb 2024 //
REUTERS
WuXi Biologics, WuXi AppTec plot expansions in US, China
08 Jan 2024 //
FIERCE PHARMA
WuXi AppTec slashes 2023 growth revenue forecast in half
30 Oct 2023 //
ENDPTS
WuXi STA Debuts First HP Sterile Injectable Mfg. Line at Wuxi Site
18 Jul 2023 //
CONTRACT PHARMA
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index
20 Dec 2022 //
PR NEWSWIRE
WuXi STA sites receive top EcoVadis scores for business sustainability rating
17 Dec 2022 //
PHARMABIZ
CDMO/CMO Report: High-Potency Manufacturing
13 Oct 2022 //
DCATVCI
WuXi STA Opens High Potency Oral Drug Product Manufacturing Facility
27 Sep 2022 //
CONTRACTPHARMA
WuXi expansion tear continues with new oral production plant
27 Sep 2022 //
FIERCEPHARMA
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility
26 Sep 2022 //
PRNEWSWIRE
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility
16 Aug 2022 //
PRNEWSWIRE
WuXi ATU Announces Licensing Agreement with Janssen for TESSA Technology
11 Aug 2022 //
PRNEWSWIRE
Altasciences kicks off client manufacturing expansion in Philadelphia
15 Jul 2022 //
ENDPTS
WuXi STA Opens High-Potency API Plant
30 Jun 2022 //
CONTRACTPHARMA
WuXi debuts another high-potency API production facility
28 Jun 2022 //
FIERCEPHARMA
Sirona Biochem Contracts WuXi AppTec to Manufacture Revolutionary Compound
22 Jun 2022 //
GLOBENEWSWIRE
WuXi Advanced Therapies and A*STAR announce partnership
28 Apr 2022 //
PRNEWSWIRE
WuXi AppTec Reports Record First-Quarter In 2022
25 Apr 2022 //
PRNEWSWIRE
Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies
11 Apr 2022 //
GLOBENEWSWIRE
Orbit Discovery, WuXi AppTec Sign Agreement to Access Peptide Discovery
07 Mar 2022 //
BUSINESSWIRE
Hemogenyx inks partnership with WuXi ATU to manufacture lentiviral vectors
21 Dec 2021 //
PHARMABIZ
WuXi ATU opens new manufacturing facility in Lin-gang, Shanghai
19 Oct 2021 //
PHARMABIZ
WuXi ATU Opens Fourth Manufacturing Facility
18 Oct 2021 //
CONTRACTPHARMA
WuXi AppTec Receives AA ESG Rating from MSCI
05 Sep 2021 //
PRNEWSWIRE
Juno, WuXi JV wins China nod for Breyanzi sister CAR-T
03 Sep 2021 //
FIERCEPHARMA
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
27 May 2021 //
PRNEWSWIRE
WuXi AppTec Acquires OXGENE to Increase Cell and Gene Therapy Offerings
02 Mar 2021 //
PHARMTECH
A `love story`: WuXi AppTec wraps UK-based CRO into its cell and gene unit
02 Mar 2021 //
ENDPTS
WuXi lays out €150M to take over Bayer plant in Germany
21 Dec 2020 //
FIERCEPHARMA
WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth
02 Dec 2020 //
PRNEWSWIRE
WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer
02 Dec 2020 //
PRNASIA
China`s price-slashing round; Takeda`s Japan cuts; Sinopharm`s COVID-19
21 Aug 2020 //
FIERCEPHARMA
Juno joint venture seeks IPO haul to bring CAR-Ts to China
17 Aug 2020 //
FIERCEBIOTECH
JW Therapeutics, today announced the completion of a US$100M Series B
10 Jun 2020 //
JWTHERAPEUTICS
David Chang steps up to CEO spot at WuXi`s cell and gene therapy CDMO
06 Jun 2020 //
ENDPTS
WuXi adds Celgene vet Chang to lead CAR-T—Chutes & Ladders
05 Jun 2020 //
FIERCE BIOTECH
WuXi AppTec names Celgene veteran to CAR-T manufacturing lead
02 Jun 2020 //
FIERCE PHARMA
